A randomised phase II study of continuous versus stop-and-go S-1 plus oxaliplatin following disease stabilisation in first-line chemotherapy in patients with metastatic gastric cancer
A new Oncology Advance study finds benefits to stop-and-go chemotherapy in treating metastatic gastric cancer. Researchers found that continuous treatment boosted progression-free... Read More
